Wegovy Reduces BMI in Kids With Obesity as Young as 6
(MedPage Today) -- NATIONAL HARBOR, Md. -- Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase III STEP Young trial. At week 68, mean body...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.